Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Sutent Prescribers for RCC: Oncologists (US)

Articles with lock require a subscription to GLG News | Request a free trial
March 14, 2008
The FDA givith (Amgen's Nplate) and takith away (Amgen's Aranesp)
Analysis of: Platelet Treatment Wins FDA Panel's Support | online.wsj.com
Author: GLG Expert Contributor
This is an agent, approved for use with restrictions, in ITP.
March 14, 2008
FDA & Epo: Not as bad as expected!
Analysis of: FDA Panel Backs Anemia Drugs For Cancer Patients, but With Limits | online.wsj.com
Author: GLG Expert Contributor
Epo products (Aranesp, Procrit, Epogen) from Amgen and J & J will be restricted to some degree with control of hemoglobin levels, NO use in curable malignancies ..." the panel voted 11 to 2 in recommending that the drugs not be used in cancer patients who are likely to be cured from their...
March 11, 2008
A third world country balking at the cost of high priced cancer drugs their citizens can't afford? Go figure....
Analysis of: Thai Ministry to Recommend Ignoring Patents on Cancer Drugs | online.wsj.com
Author: GLG Expert Contributor
Manufacturers include Roche Holding AG and Novartis AG of Switzerland and Sanofi-Aventis. Generic versions of the antineoplastic agents will be made available and the patents obviously ignored.
March 10, 2008
Amgen and J & J: FDA adding insult to injury #5
Analysis of: FDA Adds More Black-Box Warnings To Anemia Drugs From Amgen, J&J | online.wsj.com
Author: GLG Expert Contributor
The FDA is now warning of increased death & tumor growth in breast and cervical cancer patients.
March 10, 2008
Wouldn't you want 5 1/2 more months if you had metastatic breast cancer?
Analysis of: The High Cost of a Cancer Drug | www.nytimes.com
Author: GLG Expert Contributor
This editorial is questioning the use of this expensive agent in patients with metastatic breast cancer when it only increases time to progression 5.5 months.
March 7, 2008
American Cancer Society is promoting money in CaCa analysis?
Analysis of: Two Tests Added to Recommended List to Prevent or Detect Colorectal Cancer | www.nytimes.com
Author: GLG Expert Contributor
Virtual Colonoscopy and stool analysis for DNA alterations for colon cancer, are being recommended for screening.
March 6, 2008
Heparin: Unfractionated Heparin, more expensive, less effective and dangerous compared to low molecular weight varieties
Analysis of: Acute Pulmonary Embolism | content.nejm.org
Author: GLG Expert Contributor
     With recent developments in preparation of unfractionated heparins (http://www.nytimes.com/2008/03/06/health/06heparin.html?_r=1&ref=health&oref=slogin) not only are the LMWH varieties more effective as well as cheaper when all of the co factors are included, they...
March 5, 2008
Cholesterol lowering: to advertise or not???
Analysis of: Drug Pitchmen: Actor, Doctor or Pfizer’s Option | www.nytimes.com
Author: GLG Expert Contributor
"Celebrity" advertisements of percription drugs are disingenuous?
March 3, 2008
Teva Camptosar: significance?
Analysis of: Teva Announces Approval Of Generic Camptosar(R) | www.pipelinereview.com
Author: GLG Expert Contributor
Camptosar is being made in Israel I would imagine, and the price differential compared to Pfizer's brand name drug is????
February 29, 2008
Anesthesia in Colonoscopies: I have an idea for a clinical trial!
Analysis of: Aetna to Delay Reduced Colonoscopy Coverage | online.wsj.com
Author: GLG Expert Contributor
The original plan was to not provide for anesthesia support during the uncomfortable, to say the least, colonoscopys as well as upper endoscopy.

Previous Page : 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Next141 to 150 of 506

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T21:45:56.203